Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors

IMPORTANCE: Immunotherapy using immune checkpoint inhibitors has been remarkably effective for treating multiple cancer types, and the gut microbiome is a possible factor affecting immune checkpoint inhibitor efficacy. However, the association between the gut microbiome and immune status of the tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomura, Motoo, Nagatomo, Ryosuke, Doi, Keitaro, Shimizu, Juko, Baba, Kiichiro, Saito, Tomoki, Matsumoto, Shigemi, Inoue, Koichi, Muto, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163404/
https://www.ncbi.nlm.nih.gov/pubmed/32297948
http://dx.doi.org/10.1001/jamanetworkopen.2020.2895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163404/
https://www.ncbi.nlm.nih.gov/pubmed/32297948
http://dx.doi.org/10.1001/jamanetworkopen.2020.2895

Ejemplares similares